Mepitel® film versus standard care for the prevention of skin toxicity in breast cancer patients treated with adjuvant radiotherapy: A randomized controlled trial
Although the study did not demonstrate a statistically significant reduction in RTOG > 2 skin toxicity, there was evidence of a reduction in the rate of skin toxicity and an improvement in time to recovery. The device was well tolerated by patients.
Authors
- Valter Torri (ORCID: https://orcid.org/0000-0001-9541-9354)
- Andrea Puliatti
- Hansjoerg Vees
- Mariacarla Valli (ORCID: https://orcid.org/0000-0002-7880-4645)
- Dario Valcarenghi (ORCID: https://orcid.org/0000-0002-8110-3356)
- Sarah Liptrott (ORCID: https://orcid.org/0000-0001-9499-6002)
- Giovanni Presta
- Angela Tolotti (ORCID: https://orcid.org/0000-0002-2834-4345)
- Davide Sari (ORCID: https://orcid.org/0009-0002-3949-1786)
- Laura Moser
Institutions
- Mario Negri Institute for Pharmacological Research (IT)
- Ente Ospedaliero Cantonale (CH)
- Klinik Hirslanden (CH)
- Ospedale Regionale di Bellinzona e Valli (CH)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1016/j.ctro.2025.100936
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00